Grassley Requests FDA Info On Guidant ICD Alerts Following NEJM Article

Senate Finance Committee Chair Chuck Grassley (R-Iowa) is asking FDA for a detailed briefing on the "regulatory history" of Guidant's Ventak Prizm 2 DR ICD and the agency's plans to address medical device safety issues